Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
doi:10.1007/s00441-019-03016-8 Chang CH, Tsai WC, Hsu YH, Pang JH
No FDA approval for medical use
OMorain VL, Chan YH, Williams JO, Alotibi R, Alahmadi A, Rodrigues NP, Plummer SF, Hughes TR, Michael DR, Ramji DP (2021) The Lab4P consortium of probiotics attenuates atherosclerosis in LDL receptor deficient mice fed a high fat diet and causes plaque stabilization by inhibiting inflammation and several pro-atherogenic processes
Tetrazole analogs as dual cyclooxygenases-2 (COX-2)/tumor necrosis factor-alpha (TNF-) inhibitors As a continuation of the research on heterocyclic compounds with COX-2 inhibitory activity, a study conducted by Wang et al
US$ 29.92
US$ 29.63
US$ 29.87
US$ 20.09
US$ 23.66
US$ 29.10
US$ 24.16
US$ 29.78
US$ 22.58
